Summary of presentations from the 67th Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), held in Boston, Massachusetts, USA, on 11th–15th November 2016
Mia Cahill,1 *Chris Ontiveros2
1. ApotheCom, London, UK
2. ApotheCom, New York, USA
*Correspondence to Chris.Ontiveros@apothecom.com
Disclosure: This supplement has been funded by Gilead Sciences Europe Ltd. The content has been developed independently by the European Medical Journal, which has retained full editorial control. The views expressed do not necessarily reflect those of Gilead Sciences.
Acknowledgements: Writing assistance was provided by Mia Cahill and Chris Ontiveros, PhD, ApotheCom, London, UK.
Support: The publication of this article was funded by Gilead. The views and opinions expressed are those of the authors and not necessarily of Gilead.
Citation: EMJ Hepatol. 2017;5[Suppl 5]:2-12.
The Liver Meeting 2016, held by the American Association for the Study of Liver Diseases (AASLD) in Boston, Massachusetts, USA, supported the presentation of both recent clinical research and basic research in the area of liver disease from renowned experts to target the diverse needs of hepatology professionals. Posters presented on hepatitis B and oral presentations discussing chronic hepatitis infections are summarised within this article.